•  
  •  
  •  
  •  

2025-05-08 23:34:59

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Lemon Tree Hotels launches its 4th property in Goa with Lemon Tree Hotel, Anjuna
  • Route Mobile Ltd Q4 FY25 consolidated net profit falls to Rs. 56.58 crores
  • Star Housing Finance Ltd Q4 FY2024-25 PAT up at Rs. 2.97 crore
  • Linc Ltd Q4FY25 consolidated PAT higher at Rs. 12.10 crores
  • EKI Energy Services Ltd Q4 FY2025 consolidated loss at Rs. 6.24 crore

Keywords Selected:  Pharmaceuticals

Research

  • Kotak Institutional Equities - Pharmaceuticals: IPM pulse - gaining momentum
  • Company Update - P&G Health - ICICI Direct
  • Quant Pick - Cadila Healthcare - ICICI Direct
  • Q2FY22 Result Update - Syngene International - ICICI Direct
  • Syngene International Ltd - Lack of near term triggers - YES Securities
  • Syngene International Ltd - Lower gross margin lead to EBIDTA miss - YES Securities

IPO News

  • Senores Pharmaceuticals IPO subscribed 13.93 times on Day 2
  • Senores Pharmaceuticals IPO fully subscribed on Day 1
  • Senores Pharmaceuticals gets Sebi nod for IPO

Stock Report

  • Lupin launches Eslicarbazepine Acetate Tablets in the United States
  • Suven Pharmaceuticals Ltd is now Cohance Lifesciences Ltd
  • Granules India earns Gold Rating in First-Ever Corporate-Level EcoVadis Assessment Ranks in the Top 5% Globally Across All Industries
  • Kwality Pharmaceuticals Ltd concludes regulatory audit for Zimbabwe
  • Jagsonpal Pharmaceuticals Limited recommends dividend of Rs. 2.5
  • Jagsonpal Pharmaceuticals Ltd Q4 FY2025 PAT slides QoQ to Rs. 6.58 crores
  • Alembic Pharmaceuticals Ltd recommends dividend of Rs. 11
  • Alembic Pharmaceuticals Ltd posts consolidated net profit of Rs. 156.63 crores in Q4 FY2025
  • Senores Pharmaceuticals acquires ANDA for Topiramate HCl 25, 50, 100 and 200 mg tablets
  • Ichnos Glenmark Innovation receives U.S. FDA Fast Track Designation for ISB 2001 for Relapsed/Refractory Multiple Myeloma
  • Smruthi Organics Ltd approves dividend of Rs. 1.50
  • Shelter Pharma Ltd secures order from Taha Drugs & Chemicals Co. Ltd
  • Innoxel Lifesciences Pvt. Ltd. Successfully Completes U.S. FDA Inspection
  • Europe (AGES, Austria) Inspection of Shilpa Biologicals Pvt Ltd
  • Sanofi Consumer Healthcare India Ltd. Q1 results PAT up 12.9%
  • Neuland Laboratories Ltd completes USFDA inspection at Unit 2
  • Vanta Bioscience Ltd receives GLP Compliance re-certification
  • USFDA Inspection at Concord Biotech Ltd's API facility at Dholka
  • Alembic Pharmaceuticals Ltd announces USFDA Final Approval for Ticagrelor Tablets, 90 mg and Tentative Approval for Ticagrelor Tablets, 60 mg
  • SMS Pharmaceuticals Ltd's Vizag plant receives WHO Geneva prequalification
  • Fermenta enters its 75th Year, Celebrating a Legacy Built on Trust
  • Strides strengthens Anti-Inflammatory Portfolio with USFDA Approval for Celecoxib Capsules, 100 mg, 200 mg, and 400 mg
  • FDC Ltd to expand Liquid Oral facility at Sinnar Plant
  • Zydus receives final approval from USFDA for Niacin Extended-Release Tablets USP, 500 mg, 750 mg, and 1,000 mg

Industry News

  • NYSE Listed Amneal Pharmaceuticals begins Commercial Operations in India

Latest Post

  • Lemon Tree Hotels launches its 4th property in Goa with Lemon Tree Hotel, Anjuna
  • Route Mobile Ltd Q4 FY25 consolidated net profit falls to Rs. 56.58 crores
  • Star Housing Finance Ltd Q4 FY2024-25 PAT up at Rs. 2.97 crore
  • Linc Ltd Q4FY25 consolidated PAT higher at Rs. 12.10 crores
  • EKI Energy Services Ltd Q4 FY2025 consolidated loss at Rs. 6.24 crore


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024